LanthaScreenTM Eu kinase binding assay for ALK5

YZ Yifan Zhang
JW Jing Wang
SZ Sizheng Zhou
ZX Zhibo Xie
CW Chuandong Wang
YG Ya Gao
JZ Jia Zhou
XZ Xiaoling Zhang
QL Qingfeng Li
ask Ask a question
Favorite

As a verified method to detect kinase inhibitor, LanthaScreenTM Eu kinase binding assay was used to analyze the interaction of the selected flavonoids with ALK547. Kinase buffer consisting of 50 mM 4-(2-hydroxyethyl)-1- piperazineethanesulfonic acid (pH 7.5), 10 mM MgCl2, 1 mM ethyleneglycoltetraacetic acid, and 0.01% Brij-35 was used, in which 1% DMSO was added to form compound dilution buffer. A mixture of fourfold serially diluted compounds (5 μl), kinase/antibody solution (5 μl of GST-ALK5 (15 nM) and Eu-anti-GST antibody (6 nM); Invitrogen, Carlsbad, CA, USA) and kinase tracer 178 (5 μl of 30 nM; Invitrogen, Carlsbad, CA, USA) was added to each assay well in a low-volume 384-well plate (Corning Part #3676) for 1-h incubation at room temperature. Fluorescence resonance energy transfer signal was read using a Tecan Infinite F-500 plate reader. The emission ratio was defined as the acceptor/tracer emission (665 nm) divided by the antibody/donor emission (615 nm). IC50 value was determined based on the sigmoidal dose−response curve that was generated using GraphPad Prism software.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A